A new drug for the treatment of hereditary transthyretin amyloid polyneuropathy: eplontersen

ZHU Haibin , WANG Yue , LIAO Xiaolan , WU Tingting , YU Zicheng

PDF(6892 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(6892 KB)
World Clinical Drug ›› 2025, Vol. 46 ›› Issue (7) : 715. DOI: 10.13683/j.wph.2025.07.015
Review

A new drug for the treatment of hereditary transthyretin amyloid polyneuropathy: eplontersen

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 46(7): 715 https://doi.org/10.13683/j.wph.2025.07.015

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(6892 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉